首页> 外文OA文献 >Plasma D-dimer is not useful in the prediction of deep vein thrombosis after total knee arthroplasty in patients using rivaroxaban for thromboprophylaxis
【2h】

Plasma D-dimer is not useful in the prediction of deep vein thrombosis after total knee arthroplasty in patients using rivaroxaban for thromboprophylaxis

机译:血浆D-二聚体在使用亚乙酰羰基乙酰丙基乙酰基乙酰丙烷基患者的患者中总膝关节形成术后的深静脉血栓形成预测

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Abstract Background Venous thromboembolism (VTE) is a serious complication following total joint replacement. The use of rivaroxaban, a highly selective and direct factor Xa inhibitor, has been used widely as a safe and efficacious way to prevent VTE after total joint replacements. However, little is known about the diagnostic efficacy of plasma D-dimer test on deep vein thrombosis (DVT) in patients using rivaroxaban for thromboprophylaxis. The study is aimed to investigate the trend and the diagnostic efficacy of D-dimer test on DVT in patients with primary total knee arthroplasty (TKA) using rivaroxaban for thromboprophylaxis. Methods Two hundred TKA patients using rivaroxaban postoperatively as chemical prophylaxis were reviewed. D-dimer levels were checked at 4 h after the surgery and on postoperative days 1 and 4. Venography was used to document the presence of DVT. The Mann-Whitney U test was used to detect the differences in the D-dimer levels at different time points in patients with and without DVT, followed by Bonferroni corrections for p values. Receiver operating characteristics (ROC) curves were constructed to determine the best cutoff values of the D-dimer test at each time point after the surgery. Results Twenty-nine of the 200 patients were found to have deep vein thrombosis by venography, resulting in an incidence of 14.5%. All patients with DVTs occurred in the distal calf veins, and only one patient was symptomatic. We found significant differences in D-dimer concentration between patients with and without DVT at postoperative day 4. The best cutoff value determined by receiver operating characteristics analysis was 3.8 mg/L at postoperative day 4, with an AUC equal to 63.5%, and a sensitivity, specificity, PPV, and NPV of 58.6, 76, 29.3, and 91.5%, respectively. Conclusions Rivaroxaban was effective on reducing DVT in patients undergoing TKA. Because all the DVTs occurred in the leg veins, decreased thrombus volume and size might result in poor accuracy of plasma D-dimer test in prediction or diagnosis of postoperative DVT.
机译:摘要背景静脉血栓栓塞(VTE)是在总关节置换后的严重并发症。利用Rivaroxaban,一种高度选择性和直接的因子XA抑制剂,已被广泛用于防止总关节置换后的安全性和有效的方法。然而,关于使用蓖麻前丙烷的患者对患者的深静脉血栓形成(DVT)的血浆D-二聚体试验的诊断效果很少。该研究旨在探讨使用Rivaroxaban用于血浆丙基丙氨酸血管基甲基的D-DIMOR测试对D-DIMOR试验对D-DIMOR试验的趋势和诊断疗效。方法综述了二百个TKA术后牵牛草术中利用蓖麻的患者。在手术后4小时检查D-二聚体水平,并在术后第1天和4.静脉造影用于记录DVT的存在。 Mann-Whitney U测试用于检测在患者和不带DVT的不同时间点的D-二聚体水平的差异,然后是P值的Bonferroni校正。构建接收器操作特性(ROC)曲线以确定手术后每次点的D-二聚体测试的最佳截止值。结果静脉造影发现200例200名患者的二十九个患者具有深静脉血栓形成,导致发病率为14.5%。所有DVT患者发生在远端小牛静脉中,只有一名患者症状。在术后第4天,我们发现患者与没有DVT的患者的D-二聚体浓度的显着差异。术后第4天,通过接收器操作特性分析确定的最佳截止值为3.8mg / L,AUC等于63.5%,AUC等于63.5%敏感性,特异性,PPV和NPV分别为58.6,76,29.3和91.5%。结论Rivaroxaban在接受TKA患者的降低DVT有效。因为所有的DVTS发生在腿部静脉中,因此降低血栓体积和大小可能导致术后DVT预测或诊断中的等离子体D-二聚体试验的准确性差。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号